As the COVID-19 pandemic continues, medical providers are discovering new tools to battle the deadly virus. One of these tools is monoclonal antibodies, also known as mAbs. The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) of two monoclonal antibody treatments…